Senseonics (SENS) investor relations material

Executive summary

• Q2 2026 delivered record revenue of $14.5M, up 120% year-over-year, driven by strong U.S. growth and Eversense 365 adoption.

• U.S. revenue rose over 150% to $12.6M, while international revenue reached $1.9M.

• Gross margin reached a record 59%–59.1%, reflecting favorable product mix and elimination of revenue share with Ascensia.

• Net loss widened to $36.7M ($0.63/share) due to increased R&D and SG&A from commercialization transition.

• Completed U.S. and European commercialization transition from Ascensia, now recognizing 100% of related revenues.

Financial highlights

• Q2 2026 net revenue: $14.5M, up from $6.6M in Q2 2025 (120% increase).

• Gross profit: $8.6M (gross margin 59%), up from $3.1M (47%) in Q2 2025.

• Six-month 2026 revenue: $26.2M; gross profit: $15.5M (59.2% margin).

• Cash, restricted cash, and equivalents: $143M as of June 30, 2026; debt and accrued interest: $55.5M.

• Net loss for Q2 2026: $36.7M ($0.63/share); for six months: $69.0M.

Outlook and guidance

• Full-year 2026 revenue guidance raised to $62M–$66M, with gross margin guidance increased to 58%–61%.

• Revenue expected to be weighted 60% in the second half of 2026.

• Management expects existing cash and anticipated cash flows to fund operations into 2028.

• Operating expenses projected at $150M–$160M; cash utilization $110M–$120M for the year.

• Europe expected to contribute ~20% of total revenue as timing normalizes in H2.